In population-based studies, TPMT, TOR2A, KIF11, and EIF5A were reported to be associated with prognosis in other tumours, such as childhood acute lymphoblastic leukaemia [25, 26], ovarian cancer [27, 28], breast cancer [29], and colorectal cancer [30]. This evidence concerns the gene TOR2A and colorectal cancer.